{"entity":{"id":"d82d84ed-ecc2-5697-9d72-a142ce4bdeb1","name":"BARER SOL J","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001247015","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"subsidiary":{"id":"03b6fad1-921d-55db-8db6-ba841fd1a6ac","name":"CELGENE CORP /DE/","type":"Company","kind":"company","identifier":"sec:0000816284"}},{"role":"officer","share":null,"subsidiary":{"id":"03b6fad1-921d-55db-8db6-ba841fd1a6ac","name":"CELGENE CORP /DE/","type":"Company","kind":"company","identifier":"sec:0000816284"}},{"role":"director","share":null,"subsidiary":{"id":"3de85062-77bf-5f35-b402-f82e5115877b","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","type":"Company","kind":"company","identifier":"sec:0000818686"}},{"role":"director","share":null,"subsidiary":{"id":"207966ec-3ce2-5058-9d96-0d6908377cc7","name":"NEXIMMUNE, INC.","type":"Company","kind":"company","identifier":"sec:0001538210"}},{"role":"director","share":null,"subsidiary":{"id":"1250bff4-e6cb-5669-a536-4f4054da439b","name":"CONTRAFECT CORP","type":"Company","kind":"company","identifier":"sec:0001478069"}},{"role":"director","share":null,"subsidiary":{"id":"7ab53ad5-4202-5e5d-afb7-054c499320ac","name":"Avalo Therapeutics, Inc.","type":"Company","kind":"company","identifier":"sec:0001534120"}},{"role":"director","share":null,"subsidiary":{"id":"0dd57f55-66de-5cec-9505-1206245c5114","name":"AEVI GENOMIC MEDICINE, INC.","type":"Company","kind":"company","identifier":"sec:0001138776"}},{"role":"director","share":null,"subsidiary":{"id":"e2703dc3-b125-53f2-882e-5c573014d9ac","name":"PDS Biotechnology Corp","type":"Company","kind":"company","identifier":"sec:0001472091"}},{"role":"director","share":null,"subsidiary":{"id":"0365e79e-8b58-5454-9aa7-e490e1d6e0f6","name":"InspireMD, Inc.","type":"Company","kind":"company","identifier":"sec:0001433607"}},{"role":"director","share":null,"subsidiary":{"id":"9bdfcc18-7c8d-55a1-9d97-c196ea9c165d","name":"AEGERION PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0001338042"}},{"role":"director","share":null,"subsidiary":{"id":"e1a864b6-d6c1-58da-90b1-99f314115adb","name":"AMICUS THERAPEUTICS, INC.","type":"Company","kind":"company","identifier":"sec:0001178879"}},{"role":"director","share":null,"subsidiary":{"id":"5e15448a-fad5-5279-816a-1a2c0098d879","name":"CervoMed Inc.","type":"Company","kind":"company","identifier":"sec:0001053691"}},{"role":"officer","share":null,"subsidiary":{"id":"5e15448a-fad5-5279-816a-1a2c0098d879","name":"CervoMed Inc.","type":"Company","kind":"company","identifier":"sec:0001053691"}},{"role":"tenpercentowner","share":null,"subsidiary":{"id":"5e15448a-fad5-5279-816a-1a2c0098d879","name":"CervoMed Inc.","type":"Company","kind":"company","identifier":"sec:0001053691"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}